- $2.73bn
- $2.50bn
- $4.09m
AtaiBeckley surges after report says Lilly is nearing buyout deal
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports (updated)
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
Brief: Lilly Said To Near Deal For Psychedelic Drugmaker Ataibeckley- Bloomberg News
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
AtaiBeckley Q1 revenue falls, net loss widens on higher expenses
Brief: AtaiBeckley Inc Q1 EPS USD -0.08
Explainer: What to know about psychedelic therapies cited by Trump
U.S. STOCKS ON THE MOVE-Adobe, Biogen, Sable
Psychedelic drug developers rise after Trump signals regulatory support
U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO
U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen
Psychedelic drug developers rally as Trump orders FDA to expedite reviews (updated)
Psychedelic drug makers rally as Trump orders FDA to expedite reviews
Psychedelic drug developers rise after Trump signals regulatory support
Psychedelic drug developers rise after CBS report Trump backs more research
Brief: Bpl-003 Demonstrates Rapid And Durable Antidepressant Effects In Treatment-Resistant Depression Phase 2A Data Published In Journal Of Psychopharmacology Phase 3 Program On Track For Q2 2026 Initiation
U.S. STOCKS ON THE MOVE-Nuwellis, Citigroup, Meta
U.S. STOCKS ON THE MOVE-GE Vernova, Atlas Energy, Citigroup